Rational choice of cholinesterase inhibitor for the treatment of Alzheimer's disease in Canada: a comparative economic analysis

BACKGROUND: Cholinesterase inhibitors, such as galantamine, donepezil and rivastigmine are approved for symptomatic treatment of Alzheimer's Disease (AD) in Canada. In making choices amongst these drugs, one should consider their clinical merits and their economic implications. METHODS: Each dr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Caro, Jaime, Getsios, Denis, Migliaccio-Walle, Kristen, Ishak, Jack, El-Hadi, Wissam
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2003
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC317304/
https://ncbi.nlm.nih.gov/pubmed/14675494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2318-3-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge